Upload
others
View
7
Download
0
Embed Size (px)
Citation preview
RELEVANCE AND EFFECTIVE USE OF SELF-
MONITORING OF BLOOD GLUCOSE
Lori Berard, RN, CDE
Winnipeg Regional Health Authority, Health Science Centre
Winnipeg Diabetes Research Group Winnipeg, MB
PRESENTATION OUTLINE
• Objectives
• Monitoring Glycemic Control
• CDA Recommendations for SMBG
• Provincial Reimbursement
• Patient Case Scenarios
• Summary
• Discuss the benefits and value of SMBG
• Understand the 2013 Canadian Diabetes
Association SMBG recommendations for
people with diabetes, and implement them
into daily practice
• Recognize challenges in SMBG and help people
discover ways to facilitate positive outcomes
OBJECTIVES After attending this session, delegates will be able to:
Polling Question
The most effective way to determine overall glucose
control is:
a) A1c
b) Self-monitoring of blood glucose levels
c) Use of a machines “average”
d) All of the above
MONITORING
GLYCEMIC CONTROL
MEASURING BLOOD GLUCOSE LEVELS
• Glycated hemoglobin (A1C) is a reliable estimate of mean
plasma glucose (PG) levels over the previous 3 to 4 months
for most individuals
• The fasting plasma glucose (FPG) test is performed after a person
has fasted for at least 8 hours
• A postprandial plasma glucose (PPG) test measures blood glucose
levels following a meal
– Should be done 2 hours from the start of the meal
• SMBG identifies glycemic excursions to allow for day to day
adjustments of activity, diet and medication
CDA Clinical Practice Guidelines. Can J Diabetes 2013;37(Suppl 1):S1-S212;
Parkin CG, Davidson JA. J Diabetes Sci Technol. 2009;3(3):500-508.
SET TARGETS FIRST: CURRENT
RECOMMENDATIONS
For whom A1C (%) FPG (mmol/L) PPG (mmol/L)
Most adults with
Type 1 or Type 2
diabetes
≤ 7.0
4.0 – 7.0
5.0 – 10.0
5.0 – 8.0 if unable to
achieve A1C target
Pregnant women
Individualized
< 5.3 1 hour < 7.8
2 hours < 6.7
Children < 6 years < 8.0 6.0 – 10.0 —
Children 6 – 12 years ≤ 7.5 4.0 – 10.0 —
Children 13 – 18 years ≤ 7.0 4.0 – 7.0 5.0 – 10.0
Frail elderly ≤ 8.5 5.0 – 12.0 —
CDA Clinical Practice Guidelines. Can J Diabetes 2013;37(Suppl 1):S1-S212.
A1C VARIABILITY
A1C may be within the target range, but this can be achieved with
consistent blood glucose or day-to-day highs and lows
CDA Clinical Practice Guidelines. Can J Diabetes 2013;37(Suppl 1):S1-S212;
Parkin CG, Davidson JA. J Diabetes Sci Technol. 2009;3(3):500-508.
BENEFITS OF SMBG
SMBG can
• determine preprandial and postprandial hyperglycemia
• confirm hypoglycemia, allowing for appropriate treatment
• detect glycemic excursions, providing immediate feedback to
patients about the effect of food choices, activity, and medication
on glycemic control
Awareness of SMBG and A1C provide the
best information to assess glycemic control
CDA Clinical Practice Guidelines. Can J Diabetes 2013;37(Suppl 1):S1-S212;
Parkin CG, Davidson JA. J Diabetes Sci Technol. 2009;3(3):500-508.
SMBG CAN HELP IDENTIFY AND TREAT
HYPO- AND HYPERGLYCEMIA
Hypoglycemia
• Shaky, light-headed, nauseated
• Hungry
• Sweaty
• Heart rate is faster
• Weak
• A numbness or tingling in
tongue or lips
• Nervous, irritable, anxious
• Headachy
• Drowsy
• Confused, unable to concentrate
• Lose consciousness
Hyperglycemia
• Thirsty
• Urinate more often than usual,
especially during the night
• Tired, loss of energy
• Blurred vision
• Weight loss
• Pallor
CDA Publications: Lows and highs: blood glucose levels; Signs & Symptoms;
Diabetes in the Workplace: A Guide for Employers & Employees.
Polling Question
The most effective utilization of SMBG values really is:
a) Self-management decisions by the person with diabetes
b) Just a number to be written down for future discussion
c) A clinical diagnostic to help guide the health care
provided in making treatment choices
d) Only relevant if there is lots of numbers
SMBG + SELF-MANAGEMENT EDUCATION
Self-management education involves active patient participation
in self-monitoring and decision making
Self-management that incorporates SMBG may allow the person
with diabetes to make informed choices on a day to day basis
with respect to:
• Diet
• Exercise
• Medication(s)
Leading to better disease control
CDA Clinical Practice Guidelines. Can J Diabetes 2013;37(Suppl 1):S1-S212
STeP STUDY
Structured Testing Program (STeP) Study
• 12-month, prospective, cluster-randomized, multicenter study of 483
poorly controlled (A1C ≥7.5%), insulin-naïve type 2 diabetes patients
• Patients were randomized to:
– Active control group (ACG) with enhanced usual care
– Structured testing group (STG) with enhanced usual care and at least
quarterly use of SMBG
– Adherent STG (STG/a) patients used SMBG throughout the 12-month
trial. Nonadherent STG (STG/na) patients discontinued use of SMBG
during the trial
Polonsky WH, Fisher L, Schikman CH, et al. Diabetes Care. 2011;34(2):262-267
STeP STUDY
Polonsky WH, Fisher L, Schikman CH, et al. Diabetes Care. 2011;34(2):262-267
CDA RECOMMENDATIONS
FOR SMBG
Polling Question
In people with type 2 diabetes not requiring insulin, the best
evidence that SMBG makes a difference is:
a) Preventing hypoglycemia
b) Adjusting oral medications
c) Making food and activity changes when medications
cannot be adjusted
d) In newly diagnosed people with type 2 diabetes
2013 CDA GUIDELINES FOR SMBG
Recommendations for SMBG frequency can be found in the “SMBG
Recommendation Tool for Healthcare Providers” and the interactive
online “Self-SMBG Frequency & Pattern Tool”
REGULAR SMBG FREQUENCY
Situation SMBG Recommendation
Using multiple daily injections of insulin
(≥ 4 times per day)
Using an insulin pump
SMBG ≥ 4 times per day
(Suggested SMBG Pattern)
Using insulin < 4 times per day
SMBG at least as often as insulin is being given
(Suggested SMBG Pattern)
Pregnant (or planning a pregnancy),
whether using insulin or not
Hospitalized or acutely ill
SMBG individualized and may involve
SMBG ≥ 4 times per day
Starting a new medication known to cause
hyperglycemia (eg, steroids)
Experiencing an illness known to cause
hyperglycemia (eg, infection)
SMBG individualized and may involve
SMBG ≥ 2 times per day
CDA Clinical Practice Guidelines Expert Committee. Appendix 4. Can J Diabetes 2013;37(Suppl 1):S197-S212.
http://guidelines.diabetes.ca/BloodGlucoseLowering/SMBGRecommendationSheet
INCREASED SMBG FREQUENCY
Situation SMBG Recommendation
Using drugs known to cause hypoglycemia
(eg, sulfonylureas, meglitinides)
SMBG at times when symptoms of hypoglycemia
occur or at times when hypoglycemia has previously
occurred
Has an occupation that requires strict
avoidance of hypoglycemia
SMBG as often as is required by employer
Not meeting glycemic targets
SMBG ≥ 2 times per day, to assist in lifestyle and/or
medication changes until such time as glycemic
targets are met
Newly diagnosed with diabetes
(< 6 months)
SMBG ≥ 1 time per day (at different times of day) to
learn the effects of various meals, exercise and/or
medications on blood glucose
Treated with lifestyle and oral agents and is
meeting glycemic targets
Some people with diabetes might benefit from very
infrequent checking (SMBG once or twice per week)
to ensure that glycemic targets are being met
between A1C tests
CDA Clinical Practice Guidelines Expert Committee. Appendix 4. Can J Diabetes 2013;37(Suppl 1):S197-S212.
http://guidelines.diabetes.ca/BloodGlucoseLowering/SMBGRecommendationSheet
SMBG FREQUENCY
Daily SMBG is not USUALLY required if the person with
diabetes is treated only with lifestyle and is meeting
glycemic targets or has pre-diabetes
However, SMBG can be used as a teaching tool in newly
diagnosed patients who are not on medication to learn the
effects of various meals, exercise and/or medications on
blood glucose
CDA Clinical Practice Guidelines. Can J Diabetes 2013;37(Suppl 1):S1-S212.
PROVINCIAL
REIMBURSEMENT
PROVINCIAL REIMBURSEMENT
• Reimbursement for blood glucose test strips for people with diabetes
varies from province to province and for different groups such as
seniors, low income individuals and those on social assistance.
• Some provinces, like Ontario and British Columbia, have instituted
coverage limitations for certain patient profiles, based on an
individual’s current diabetes therapy. Other provinces are expected
to follow.
• Additional test strips may be reimbursed for people who have been
directed by a healthcare professional for clinical reasons, to monitor
blood glucose levels more closely
ONTARIO AND BRITISH COLUMBIA
CDA Clinical Practice Guidelines Expert Committee. Appendix 4. Can J Diabetes 2013;37(Suppl 1):S197-S212.
http://guidelines.diabetes.ca/BloodGlucoseLowering/SMBGRecommendationSheet
Treatment Category Annual Quantity Limit
Managing diabetes with insulin
3,000 test strips
Managing diabetes with anti-diabetes
medications with a high risk of causing
hypoglycemia (low blood sugar)
400 test strips
Managing diabetes with anti-diabetes
medications with a low risk of causing
hypoglycemia (low blood sugar)
200 test strips
Managing diabetes through diet/lifestyle therapy
only (no insulin or anti-diabetes medications)
200 test strips
Take a few moments to discuss your personal
experiences with reimbursement structures in
your area.
• Do you or your patients face
any challenges?
• How do you counsel patients on
optimizing testing?
PROVINCIAL REIMBURSEMENT Group Discussion
PATIENT CASE SCENARIOS
SMBG FREQUENCY AND PATTERNS
As mentioned earlier, the Canadian Diabetes Association interactive
SMBG Frequency & Pattern Tool can be used to help individualize
monitoring for patients. The tool can be found at
http://guidelines.diabetes.ca/bloodglucoselowering/smbgtool
SMBG frequency and patterns are recommended
by answering the following:
• What type of diabetes does your patient have?
• Is your patient's A1C to target (typically ≤7.0%)?
• What drug(s) does your patient take for their type 2 diabetes?
• How often does your patient use insulin?/What type of insulin?
• Is your patient sick or starting a steroid drug?
• Has your patient recently been diagnosed with diabetes
(<6 months)?
PATIENT SCENARIO: ANNE
Patient Information:
• 45-year-old white female, Type 2
• 5’5 and 190 lbs (BMI of 31.6)
Medication:
• No Medication
Medical Information:
• Diagnosed 3 months ago
• A1C of 7.5% (target 7.0%)
PATIENT SCENARIO: ANNE
Frequency Recommendation:
• SMBG once or more per day at different times of day to learn
effects of meals, exercise, medication(s)
Pattern Recommendation:
• Diagnosis of type 2 diabetes in the past 6 months or
not meeting glycemic targets
Choose one of the recommended SMBG patterns
CDA Clinical Practice Guidelines Self-Monitoring Blood Glucose (SMBG) Frequency & Pattern Tool:
http://guidelines.diabetes.ca/bloodglucoselowering/smbgtool
PATIENT SCENARIO: ANNE
What if Anne was diagnosed 9 months ago?
Frequency Recommendation:
• SMBG 1 or more times per day
Pattern Recommendation:
• Diagnosis of type 2 diabetes in the past 6 months or
not meeting glycemic targets
• No change from previously recommended SMBG patterns
CDA Clinical Practice Guidelines Self-Monitoring Blood Glucose (SMBG) Frequency & Pattern Tool:
http://guidelines.diabetes.ca/bloodglucoselowering/smbgtool
PATIENT SCENARIO: ANNE
What if Anne was diagnosed 9 months ago
and is at target?
Frequency Recommendation:
• Infrequent SMBG recommended; 1 or 2 times per week
Pattern Recommendation:
• Type 2 diabetes treated with lifestyle and oral agents AND is meeting
glycemic targets; If on a secretagogue, check also when
hypoglycemia is suspected or has occurred
Recommended SMBG pattern
CDA Clinical Practice Guidelines Self-Monitoring Blood Glucose (SMBG) Frequency & Pattern Tool:
http://guidelines.diabetes.ca/bloodglucoselowering/smbgtool
PATIENT SCENARIO: JOSEPH
Patient Information:
• 52-year-old white male, Type 2
• 5’11 and 215 lbs (BMI of 30)
Medication:
• Metformin 1 g, PO, BID
Medical Information:
• Diagnosed 14 months ago
• A1C of 7.9% (target 7.0%)
PATIENT SCENARIO: JOSEPH
Frequency Recommendation:
• SMBG once or more per day at different times of day to learn
effects of meals, exercise, medication(s)
Pattern Recommendation:
• Diagnosis of type 2 diabetes in the past 6 months or
not meeting glycemic targets
Choose one of the recommended SMBG patterns
CDA Clinical Practice Guidelines Self-Monitoring Blood Glucose (SMBG) Frequency & Pattern Tool:
http://guidelines.diabetes.ca/bloodglucoselowering/smbgtool
PATIENT SCENARIO: JOSEPH
What if one year later, Joseph is taking insulin once
daily and has an A1C of 8.5?
Frequency Recommendation:
• SMBG 2 or more times a day until targets are met
Pattern Recommendation:
• Basal Insulin Only (Not To Target)
Recommended SMBG pattern
CDA Clinical Practice Guidelines Self-Monitoring Blood Glucose (SMBG) Frequency & Pattern Tool:
http://guidelines.diabetes.ca/bloodglucoselowering/smbgtool
PATIENT SCENARIO: JOSEPH
What if one year later, Joseph is taking insulin once
daily and has an A1C of 6.8?
Frequency Recommendation:
• SMBG at least as often as insulin is given
Pattern Recommendation:
• Basal Insulin Only (To Target)
Recommended SMBG pattern
CDA Clinical Practice Guidelines Self-Monitoring Blood Glucose (SMBG) Frequency & Pattern Tool:
http://guidelines.diabetes.ca/bloodglucoselowering/smbgtool
DIAGNOSIS OF TYPE 2 DIABETES IN THE
PAST 6 MONTHS OR NOT MEETING
GLYCEMIC TARGETS
Return to Presentation
CDA Clinical Practice Guidelines. Can J Diabetes 2013;37(Suppl 1):S1-S212.
TYPE 2 DIABETES TREATED WITH
LIFESTYLE AND ORAL AGENTS AND
IS MEETING GLYCEMIC TARGETS
Return to Presentation
CDA Clinical Practice Guidelines. Can J Diabetes 2013;37(Suppl 1):S1-S212.
DIAGNOSIS OF TYPE 2 DIABETES IN THE
PAST 6 MONTHS OR NOT MEETING
GLYCEMIC TARGETS
Return to Presentation
CDA Clinical Practice Guidelines. Can J Diabetes 2013;37(Suppl 1):S1-S212.
BASAL INSULIN ONLY (NOT TO TARGET)
Return to Presentation
CDA Clinical Practice Guidelines. Can J Diabetes 2013;37(Suppl 1):S1-S212.
BASAL INSULIN ONLY (TO TARGET)
Return to Presentation
CDA Clinical Practice Guidelines. Can J Diabetes 2013;37(Suppl 1):S1-S212.
SUGGESTED SMBG PATTERNS
FOR PATIENTS USING INSULIN
Next Slide
CDA Clinical Practice Guidelines. Can J Diabetes 2013;37(Suppl 1):S1-S212.
SUGGESTED SMBG PATTERNS
FOR PATIENTS USING INSULIN
Return to Presentation
CDA Clinical Practice Guidelines. Can J Diabetes 2013;37(Suppl 1):S1-S212.
SUMMARY
• SMBG can provide immediate feedback to patients about the effect of
food choices, activity, and medication on glycemic control
• Its benefits are enhanced when used by patients and healthcare
providers to respond with adjustments to:
– Dietary choices
– Physical activity
– Medication(s)
• The pattern recommendations discussed should be used as
guidelines to individualize SMBG patterns and care
THANK YOU!